Leaflet: information for the user
escitalopram cinfa 10 mg film-coated tablets
escitalopram oxalate
Read this leaflet carefully before you start to take this medicine because it contains important information for you.
Escitalopram cinfa containsthe active ingredientescitalopram. Escitalopram belongs to a group of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). These medications act on the serotonin system in the brain by increasing the level of serotonin. Alterations in the serotonin system are considered an important factor in the development of depression and related diseases.
Escitalopram cinfa is indicated for the treatment of depression (major depressive episodes) and anxiety disorders (such as panic disorder with or without agoraphobia, social anxiety disorder, generalized anxiety disorder, and obsessive-compulsive disorder)
You may notice an improvement in a couple of weeks. Continue taking escitalopram cinfa even if it takes time to notice some improvement.
You should consult a doctor if you get worse or do not improve.
No take escitalopram cinfa
Warnings and precautions
Consult your doctor or pharmacist before starting to take escitalopram cinfa.
Please inform your doctor if you have any other medical condition or disease, as your doctor may need to take it into account. In particular, inform your doctor:
Some medications in the group to which escitalopram belongs (called SSRIs/SNRIs) may cause sexual dysfunction symptoms (see section 4). In some cases, these symptoms persist after discontinuing treatment.
Please note
Some patients with manic-depressive illness may enter a manic phase. This is characterized by unusual and rapid changes in ideas, excessive joy, and excessive physical activity. If you experience this, contact your doctor.
Symptoms such as restlessness or difficulty sitting or standing may also occur during the first weeks of treatment. Inform your doctor immediately if you experience these symptoms.
Thoughts of suicide and worsening of depression or anxiety disorder
If you are depressed and/or have an anxiety disorder, you may occasionally have thoughts of harming yourself or committing suicide. These may increase when taking antidepressants for the first time, as all these medications require time to start working, usually around two weeks, although in some cases it may take longer.
You would be more prone to having these thoughts:
If you ever have thoughts of harming yourself or committing suicide, contact your doctor or go directly to a hospital.
It may be helpful for you to tell a family member or close friendthat you are depressed or have an anxiety disorder and ask them to read this leaflet. You can ask them if they think your depression or anxiety disorder has worsened. Or if they are concerned about changes in your attitude.
Children and adolescents
Escitalopram should not be used normally in the treatment of children and adolescents under 18 years old. Also, be aware that in patients under 18 years old, there is a higher risk of adverse effects such as suicidal attempts, suicidal thoughts, and hostility (mainly aggression, confrontational behavior, and irritability) when taking this type of medication. However, your doctor may prescribe escitalopram to patients under 18 years old when they decide what is best for the patient. If the doctor who prescribed escitalopram to you wants to discuss this decision, please go back to your doctor. You should inform your doctor if any of the symptoms described above progress or if you experience complications when patients under 18 years old are taking escitalopram. At the same time, the long-term effects regarding safety and related to growth, maturity, and cognitive and behavioral development of escitalopram in this age group have not yet been demonstrated.
Taking escitalopram cinfa with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Inform your doctor if you are taking any of the following medications:
Do not take escitalopram if you are taking medications for heart rhythm problems or that may affect heart rhythm, for example, antiarrhythmic Class IA and III, antipsychotics (e.g. phenothiazine derivatives, pimozide, haloperidol), tricyclic antidepressants, some antimicrobial agents (e.g. sparfloxacin, moxifloxacin, erythromycin IV, pentamidine, particular antimalarial treatment halofantrine), some antihistamines (astemizole, mizolastine).
Contact your doctor for any additional consultation.
Taking escitalopram cinfa with food, drinks, and alcohol
Escitalopram can be taken with or without food (see section 3 "How to take escitalopram cinfa").
As with many medications, it is not recommended to combine escitalopram and alcohol, although it is not expected to interact with alcohol.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
Do not take escitalopram if you are pregnant or breastfeeding unless you and your doctor have analyzed the risks and benefits involved.
If you take escitalopram during the last 3 months of your pregnancy, be aware that the following effects may be observed in the newborn: difficulty breathing, blue skin, seizures, changes in body temperature, difficulty feeding, vomiting, low blood sugar, muscle stiffness or weakness, intense reflexes, tremors, restlessness, irritability, drowsiness, and difficulty falling asleep. If your newborn has any of these symptoms, please contact your doctor immediately.
If you take escitalopram in the final stages of pregnancy, there may be an increased risk of heavy vaginal bleeding shortly after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking escitalopram to be able to advise you.
Make sure your midwife and/or doctor know that you are being treated with escitalopram.
During pregnancy, especially in the last 3 months, medications like escitalopram may increase the risk of a serious condition in newborns, called persistent pulmonary hypertension of the newborn (PPHN), in which the baby breathes rapidly and turns blue. These symptoms usually start within the first 24 hours after birth. If they appear in your baby, contact your midwife and/or doctor immediately.
Escitalopram should not be discontinued abruptly if used during pregnancy. It is expected that escitalopram will be excreted through breast milk.
Citalopram, a medication similar to escitalopram, has been shown to reduce sperm quality in animal models. Theoretically, this effect could affect fertility, but to date, it has not been observed in human fertility.
Driving and operating machinery
During treatment with escitalopram, you may feel drowsy or dizzy. Do not drive or operate tools or machines until you know how escitalopram affects you.
Escitalopram cinfa contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medication.
Escitalopram cinfa contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; that is, it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.Consult your doctor or pharmacist again if in doubt.
The usual recommended dose of escitalopram is 10 mg taken as a single dose per day. Your doctor may increase it up to a maximum of 20 mg per day.
The usual recommended dose of escitalopram is 10 mg taken as a single dose per day. Your doctor may increase it up to a maximum of 20 mg per day.
The usual recommended dose of escitalopram is 10 mg taken as a single dose per day. Your doctor may decrease your dose to 5 mg per day or increase the dose up to a maximum of 20 mg per day, depending on how you respond to the medication.
The usual recommended dose of escitalopram is 10 mg taken as a single dose per day. Your doctor may increase it up to a maximum of 20 mg per day.
Older adults (65 years and older)
The initial recommended dose of escitalopram is 5 mg taken as a single dose per day. Your doctor may increase it up to 10 mg per day.
Use in children and adolescents
Escitalopram should not normally be administered to children and adolescents. For additional information, please see the section 2. "Warnings and precautions".
How to take the tablets
You can take escitalopram with or without food. Swallow the tablets with water. Do not chew the tablets, as they have an unpleasant taste.
The tablet can be split into equal doses.
If necessary, you can split the tablets by placing the tablet on a flat surface with the notch facing upwards. The tablets can be split by pressing with your two index fingers downwards, on each end of the tablet.
You may feel better in a couple of weeks. Continue taking escitalopram even if you start feeling better before the expected time.
Do not change the medication dose without talking to your doctor first.
Continue taking escitalopram for the recommended time by your doctor. If you interrupt the treatment too soon, symptoms may reappear. It is recommended that treatment continue for at least 6 months after feeling well again.
If you take more escitalopram than you should
Some signs of overdose may include dizziness, tremor, agitation, convulsion, coma, nausea, vomiting, changes in heart rhythm, decreased blood pressure, and changes in the body's electrolyte balance. Bring the escitalopram packaging with you to the doctor or hospital.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested. Do so even if you do not observe any discomfort or signs of intoxication.
If you forget to take escitalopram
Do not take a double dose to compensate for the missed doses. If you forget to take a dose and remember before going to bed, take it immediately. The next day, follow your usual schedule.
If you remember during the night or the next day, leave the missed dose and follow your usual schedule.
If you interrupt the treatment with escitalopram
Do not interrupt the treatment with escitalopram until your doctor tells you to. When you have finished your treatment course, it is usually recommended that the escitalopram dose be gradually reduced over several weeks.
When you stop taking escitalopram, especially if it is done abruptly, you may experience withdrawal symptoms. These are common when escitalopram treatment is suspended. The risk is higher when escitalopram has been used for a long time, at high doses, or when the dose is reduced too quickly. Most people find that these symptoms are mild and disappear on their own in two weeks. However, in some patients, they can be intense or prolonged (2-3 months or more). If you experience severe withdrawal symptoms when stopping escitalopram, please contact your doctor. They may ask you to take your tablets again and taper off them more slowly.
Withdrawal symptoms include: feeling of dizziness (unstable or without balance), feeling of tingling, feeling of prickling, and (less frequently) feeling of electric shock, even in the head, sleep disturbances (too intense dreams, nightmares, inability to sleep), feeling of restlessness, headache, feeling of nausea (dizziness), sweating (including nocturnal sweating), feeling of anxiety or agitation, tremor (unsteadiness), feeling of confusion or disorientation, feelings of emotion or irritability, diarrhea (loose stools), visual disturbances, rapid heartbeat or palpitations.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Side effects usually disappear after a few weeks of treatment. Please be aware that many of the side effects may be symptoms of your illness and will therefore improve as you begin to feel better.
If you have any of the following symptoms, contact your doctor or go to the hospital immediately:
Rare(may affect up to 1 in 100 patients):
-Unusual bleeding, including gastrointestinal bleeding.
Uncommon(may affect up to 1 in 1,000 patients):
Frequency not known(cannot be estimated from available data):
In addition to the above, the following side effects have been reported:
Very common(may affect more than 1 in 10 patients):
Common(may affect up to 1 in 10 patients):
Rare(may affect up to 1 in 100 patients):
Uncommon(may affect up to 1 in 1,000 patients):
Frequency not known(cannot be estimated from available data):
Other side effects that appear with medications that act similarly to escitalopram (the active ingredient in escitalopram) are known:
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
This medication does not require special conditions for conservation.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of escitalopram cinfa
Appearance of the product and content of the packaging
Escitalopram cinfa is presented in the form of cylindrical, biconvex, scored, coated, white tablets, marked with the code “ES1”.
Escitalopram cinfa is presented in packaging with 28, 56, or 500 (clinical packaging) tablets.
Only some packaging sizes may be commercially available.
Holder of the marketing authorization and responsible manufacturer:
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Industrial Park Areta
31620 Huarte (Navarra) - Spain
Last review date of this leaflet : January 2021
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) www.aemps.gob.es/
You can access detailed and updated information on this medication by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/71430/P_71430.html
QR code to: https://cima.aemps.es/cima/dochtml/p/71430/P_71430.html
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.